Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Jump to bottom

Update snapshots after fix in the wrapping + newline support #68

Merged
merged 11 commits into from
Oct 17, 2023
Merged

Update snapshots after fix in the wrapping + newline support #68

Show file tree
Hide file tree
Changes from all commits
Commits
Show all changes
11 commits
Select commit Hold shift + click to select a range
fc2d64c
Update snapshots after fix in the wrapping + newline support
Melkiades Oct 16, 2023
e70507f
refix
Melkiades Oct 16, 2023
23046e2
update with new topleft align vertical
Melkiades Oct 16, 2023
6879c75
update
Melkiades Oct 16, 2023
d1a5da3
updates
Melkiades Oct 16, 2023
95ba116
real fix
Melkiades Oct 16, 2023
8d8b4a6
fix
Melkiades Oct 16, 2023
7565aea
it seems reasonable
Melkiades Oct 16, 2023
9cd1ccf
fixes now
Melkiades Oct 16, 2023
4693051
fix
Melkiades Oct 16, 2023
39c3226
Update tests/testthat/test-pagination_table.R
Melkiades Oct 16, 2023
File filter

Filter by extension

Filter by extension
Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
54 changes: 27 additions & 27 deletions tests/testthat/_snaps/pagination_table.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -45,9 +45,9 @@
titles

—————————————————————————————————————————————
SOME A: Drug B: C: Combina
TOPLEFT X Placebo tion
(N=134) (N=134) (N=132)
A: Drug B: C: Combina
SOME X Placebo tion
TOPLEFT (N=134) (N=134) (N=132)
—————————————————————————————————————————————
- Any 122 123 120
Grade - (91.0%) (91.8%) (90.9%)
Expand Down Expand Up @@ -80,7 +80,7 @@
- 50 45 63 (47.7%)
Any (37.3%) (33.6%)
Grad
e
e -
Grad 50 45 63 (47.7%)
e (37.3%) (33.6%)
1-2
Expand All @@ -92,7 +92,7 @@
- 48 48 50 (37.9%)
Any (35.8%) (35.8%)
Grad
e
e -
Grad 48 48 50 (37.9%)
e (35.8%) (35.8%)
1-2
Expand Down Expand Up @@ -122,9 +122,9 @@
titles

—————————————————————————————————————————————
SOME A: Drug B: C: Combina
TOPLEFT X Placebo tion
(N=134) (N=134) (N=132)
A: Drug B: C: Combina
SOME X Placebo tion
TOPLEFT (N=134) (N=134) (N=132)
—————————————————————————————————————————————
cl D.1
- Any 79 67 80 (60.6%)
Expand All @@ -141,7 +141,7 @@
- 48 42 50 (37.9%)
Any (35.8%) (31.3%)
Grad
e
e -
Grad 48 42 50 (37.9%)
e (35.8%) (31.3%)
3-4
Expand All @@ -160,7 +160,7 @@
- 47 58 57 (43.2%)
Any (35.1%) (43.3%)
Grad
e
e -
Grad 47 58 57 (43.2%)
e (35.1%) (43.3%)
1-2
Expand All @@ -177,7 +177,7 @@
- 47 49 43 (32.6%)
Any (35.1%) (36.6%)
Grad
e
e -
Grad 47 49 43 (32.6%)
e 5 (35.1%) (36.6%)
—————————————————————————————————————————————
Expand All @@ -201,9 +201,9 @@
titles

—————————————————————————————————————————————
SOME A: Drug B: C: Combina
TOPLEFT X Placebo tion
(N=134) (N=134) (N=132)
A: Drug B: C: Combina
SOME X Placebo tion
TOPLEFT (N=134) (N=134) (N=132)
—————————————————————————————————————————————
cl A.1
- Any 78 75 89 (67.4%)
Expand All @@ -220,7 +220,7 @@
- 48 48 50 (37.9%)
Any (35.8%) (35.8%)
Grad
e
e -
Grad 48 48 50 (37.9%)
e (35.8%) (35.8%)
1-2
Expand Down Expand Up @@ -254,8 +254,8 @@
titles

——————————————————————————————————————————————————————————————
SOME TOPLEFT A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
SOME TOPLEFT (N=134) (N=134) (N=132)
——————————————————————————————————————————————————————————————
cl C.1
- Any Grade - 43 (32.1%) 46 (34.3%) 43 (32.6%)
Expand Down Expand Up @@ -293,8 +293,8 @@
titles

——————————————————————————————————————————————————————————————
SOME TOPLEFT A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
SOME TOPLEFT (N=134) (N=134) (N=132)
——————————————————————————————————————————————————————————————
cl C.1
- Any Grade - 43 (32.1%) 46 (34.3%) 43 (32.6%)
Expand Down Expand Up @@ -332,8 +332,8 @@
titles

———————————————————————————————————————————————————————————————————
SOME TOPLEFT A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
SOME TOPLEFT (N=134) (N=134) (N=132)
———————————————————————————————————————————————————————————————————
- Any Grade - 122 (91.0%) 123 (91.8%) 120 (90.9%)
Grade 1-2 13 (9.7%) 19 (14.2%) 11 (8.3%)
Expand Down Expand Up @@ -444,8 +444,8 @@
titles

——————————————————————————————————————————————————————————————
SOME TOPLEFT A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
SOME TOPLEFT (N=134) (N=134) (N=132)
——————————————————————————————————————————————————————————————
cl D.2
- Any Grade - 47 (35.1%) 58 (43.3%) 57 (43.2%)
Expand Down Expand Up @@ -478,8 +478,8 @@
titles

——————————————————————————————————————————————————————————————
SOME TOPLEFT A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
SOME TOPLEFT (N=134) (N=134) (N=132)
——————————————————————————————————————————————————————————————
cl C.2
- Any Grade - 35 (26.1%) 48 (35.8%) 55 (41.7%)
Expand Down Expand Up @@ -527,8 +527,8 @@
titles

——————————————————————————————————————————————————————————————
SOME TOPLEFT A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
SOME TOPLEFT (N=134) (N=134) (N=132)
——————————————————————————————————————————————————————————————
cl C.2
- Any Grade - 35 (26.1%) 48 (35.8%) 55 (41.7%)
Expand Down
7 changes: 3 additions & 4 deletions tests/testthat/_snaps/table_adat03.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -3,10 +3,9 @@
Code
res
Output
Treatment Group
Visit Total Number Samples with
Melkiades marked this conversation as resolved.
Show resolved Hide resolved
of Measurable Concentration
Samples {1} Mean SD Median Minimum Maximum CV (%) Geometric Mean ≤ 15μg/mL {2}
Total Number Samples with
Treatment Group of Measurable Concentration
Visit Samples {1} Mean SD Median Minimum Maximum CV (%) Geometric Mean ≤ 15μg/mL {2}
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
A: Drug X (N=536)
Day 1 402 0.000e+00 0.000e+00 0.000e+00 0.000e+00 0.000e+00 NA NA 402 (100%)
Expand Down
4 changes: 2 additions & 2 deletions tests/testthat/_snaps/table_aet01_aesi.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -118,8 +118,8 @@
Code
res
Output
Standardized MedDRA Query A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
Standardized MedDRA Query (N=134) (N=134) (N=132)
——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
C.1.1.1.3/B.2.2.3.1 AESI (BROAD)
Total number of patients with at least one AE 58 (43.3%) 60 (44.8%) 66 (50.0%)
Expand Down
4 changes: 2 additions & 2 deletions tests/testthat/_snaps/table_aet02.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -157,8 +157,8 @@
Code
res
Output
MedDRA Preferred Term A: Drug X B: Placebo C: Combination
(N=134) (N=134) (N=132)
A: Drug X B: Placebo C: Combination
MedDRA Preferred Term (N=134) (N=134) (N=132)
————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one adverse event 100 (74.6%) 98 (73.1%) 103 (78.0%)
Total number of events 502 480 604
Expand Down
6 changes: 3 additions & 3 deletions tests/testthat/_snaps/table_aet06.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -46,9 +46,9 @@
Code
res
Output
Body System or Organ Class A: Drug X B: Placebo C: Combination
Dictionary-Derived Term <18.5 18.5 - 24.9 25 - 29.9 >30 <18.5 18.5 - 24.9 25 - 29.9 >30 <18.5 18.5 - 24.9 25 - 29.9 >30
(N=44) (N=17) (N=11) (N=62) (N=37) (N=18) (N=10) (N=69) (N=28) (N=20) (N=18) (N=66)
A: Drug X B: Placebo C: Combination
Body System or Organ Class <18.5 18.5 - 24.9 25 - 29.9 >30 <18.5 18.5 - 24.9 25 - 29.9 >30 <18.5 18.5 - 24.9 25 - 29.9 >30
Dictionary-Derived Term (N=44) (N=17) (N=11) (N=62) (N=37) (N=18) (N=10) (N=69) (N=28) (N=20) (N=18) (N=66)
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one adverse event 41 (93.2%) 14 (82.4%) 11 (100%) 56 (90.3%) 35 (94.6%) 16 (88.9%) 9 (90.0%) 63 (91.3%) 25 (89.3%) 19 (95.0%) 15 (83.3%) 61 (92.4%)
Overall total number of events 186 80 66 277 174 89 47 312 137 129 100 337
Expand Down
4 changes: 2 additions & 2 deletions tests/testthat/_snaps/table_aovt02.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -3,8 +3,8 @@
Code
res
Output
Parameter ARM A ARM B ARM C
(N=134) (N=134) (N=132)
ARM A ARM B ARM C
Parameter (N=134) (N=134) (N=132)
———————————————————————————————————————————————————————————————————————————————————————————
Unadjusted comparison
n 68 73 62
Expand Down
6 changes: 3 additions & 3 deletions tests/testthat/_snaps/table_cfbt01.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -3,9 +3,9 @@
Code
res
Output
Parameter A: Drug X B: Placebo C: Combination
Analysis Visit Change from Change from Change from
Value at Visit Baseline Value at Visit Baseline Value at Visit Baseline
A: Drug X B: Placebo C: Combination
Parameter Change from Change from Change from
Analysis Visit Value at Visit Baseline Value at Visit Baseline Value at Visit Baseline
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
BFI All Questions
BASELINE
Expand Down
Loading